Multiple Sclerosis Comprehensive Care Center, NYU Langone Medical Center

New York, New York 10016

0 studies enrolling now · 2 studies all time

What they study most

Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder

Studies at this site

• An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients — Completed
• A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study) — Stopped early